Kolexia
Lauridant Geraldine
Oncologie médicale
Clinique Teissier
Valenciennes, France
70 Activités
106 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Carcinome pulmonaire non à petites cellules Tumeurs du poumon Métastase tumorale Carcinomes Carcinome épidermoïde Carcinome canalaire du sein Fatigue Transformation cellulaire néoplasique

Industries

A+A
40 collaboration(s)
Dernière en 2022
Novartis
16 collaboration(s)
Dernière en 2023
AstraZeneca
12 collaboration(s)
Dernière en 2023
Sanofi
3 collaboration(s)
Dernière en 2022

Dernières activités

RIBOLARIS: Neoadjuvant and Adjuvant Ribociclib and Endocrine Therapy for Clinically High-risk Estrogen Receptor-positive (ER+) and HER2-negative (HER2-) Breast Cancer
Essai Clinique (Novartis)   06 octobre 2023
Research and Analysis of the Mechanisms Involved in the Emergence of Breast Cancer Stem Cells (RepriM): Research and Analysis of the Mechanisms Involved in the Emergence of Breast Cancer Stem Cells
Essai Clinique (Centre Oscar-Lambret)   18 octobre 2021
La recherche clinique en pneumologie par le Docteur Géraldine Lauridant, oncologue médicale.
Youtube @ Groupe AHNAC   01 octobre 2021
Brief Hospital Supervision of Exercise and Diet During Adjuvant Breast Cancer Therapy Is Not Enough to Relieve Fatigue: A Multicenter Randomized Controlled Trial.
Nutrients   09 octobre 2020
KALICOU3: Evaluation of the Impact of Emotional Skills of Young Women (≤ 45 Years), With Non-metastatic Breast Cancer, and Their Partner on Adjustment to Cancer
Essai Clinique (Centre Oscar-Lambret)   24 juin 2019
BreastIls: Endogenous Mechanisms of Inactivation of the Endothelium Tumor
Essai Clinique (Centre Oscar-Lambret)   11 septembre 2018
Neuroendocrine tumors of the breast: Myth or reality? A systematic review.
Bulletin du cancer   19 mars 2018
Systematic Screening for Occupational Exposures in Lung Cancer Patients: A Prospective French Cohort.
International journal of environmental research and public health   04 janvier 2018
Paclitaxel once weekly (wP) combined with fixed dose of oral metronomic cyclophosphamide (OMC): A dose-escalating phase I trial.
2017 ASCO Annual Meeting I   30 mai 2017
High expression levels of egfl7 correlate with low endothelial cell activation in peritumoral vessels of human breast cancer.
Oncology letters   28 juin 2016